The U.S. Preventive Services Task Force: Putting evidence-based medicine to work

Clinical Obstetrics and Gynecology

Volumn 41, Issue 2, 1998, Pages 332-342

  Grimes, David A ^a   Atkins, David ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CHEMOPROPHYLAXIS; EVIDENCE BASED MEDICINE; FETUS MONITORING; OVARY CANCER; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SCREENING TEST;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; FETAL MONITORING; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS; PREGNANCY; PREVENTIVE MEDICINE; UNITED STATES;

EID: 0031806615     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199806000-00013     Document Type: Review

References (17)

1. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Baltimore, MD: Williams and Wilkins, 1995.
2. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Canada Communication Group, 1994.
3. Woolf SH, DiGuiseppi CG, Atkins D, Kamerow DB. Developing evidence-based clinical practice guidelines: Lessons learned by the U.S. Preventive Services Task Force. Ann Rev Public Health 1996;17:511-538.
4. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
5. Gold M, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996.
6. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993; 270:2207-2212.
7. Flood AB, Wennberg J, Ease RF, et al. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med 1996;11:342-349.
8. National Center for Health Statistics. Advance report of maternal and infant health data from the birth certificate, 1991. Monthly vital statistics report; vol 42 no 11. Hyattsville, MD: Public Health Service, 1994.
9. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst. 1997;89;1015-1026.
10. Carlson KJ, Skates SJ, Singer DE. Screening for ovarian cancer. Ann Intern Med 1994;121:124-132.
11. Enkin M, Keirse MJNC, Renfrew M, Neilson J. A Guide to Effective Care in Pregnancy and Childbirth. 2nd ed. Oxford: Oxford University Press, 1995:60-72.
12. Vintzileos AM, Nochimson DJ, Antsaklis A, Varvarigos I, Guzman ER, Knuppel RA. Comparison of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation in detecting fetal acidemia at birth. Am J Obstet Gynecol 1995; 173:1021-1024.
13. Vintzileos AM, Antsaklis A, Varvarigos I, Papas C, Sofatzis I, Montgomery JT. A randomized trial of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation. Obstet Gynecol 1993;81:899-907.
14. Thacker SB, Stroup DF, Peterson HB. Efficacy and safety of intrapartum electronic fetal monitoring: An update. Obstet Gynecol 1995;86:613-620.
15. The Collaborative Home Uterine Monitor- ing Study (CHUMS) Group. A multicenter randomized controlled trial of home uterine monitoring: Active versus sham device. Am J Obstet Gynecol 1995;173:1120-1127.
16. Blank A, Metzger BE, Grave GD. Effects of gestational diabetes on perinatal morbidity reassessed. Diabetes Care 1995;18:127-129.
17. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996;312:71-72.